Runda Medical(SH:603108) Zheng Quan Zhi Xing·2025-08-26 10:24Core Viewpoint - The document outlines the insider information management system of Shanghai RunDa Medical Technology Co., Ltd, emphasizing the importance of confidentiality and compliance with relevant laws and regulations to protect investors' rights [1][2][3]. Group 1: General Principles - The company establishes this system to regulate insider information management and enhance confidentiality [1]. - The board of directors is designated as the management body for insider information, with the chairman responsible for confidentiality efforts [1][2]. Group 2: Scope of Insider Information - Insider information is defined as unpublicized information that significantly impacts the company's operations, finances, or stock market prices [2][3]. - Individuals classified as insider information recipients include those specified in the Securities Law [2][3]. Group 3: Registration Management of Insider Information Recipients - The company must accurately document all stages of insider information handling, including reporting, transmission, and disclosure [3][4]. - Insider information recipients are required to confirm their awareness of the information [3][4]. Group 4: Confidentiality Management - All directors and insiders must maintain confidentiality before public disclosure and limit the information's knowledge to a minimum [6][7]. - Insider information recipients are prohibited from leaking information or trading based on insider knowledge [6][7]. Group 5: Accountability - The company will conduct self-inspections regarding insider trading and report any violations to regulatory authorities [8][9]. - Violations of the insider information management system may lead to penalties or legal actions against responsible individuals [8][9]. Group 6: Appendices - The document includes templates for the registration of insider information recipients and a commitment letter to ensure compliance with confidentiality obligations [10][11].